Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Top Stories > $150 MILLION IN CONTRACT VALUE: DARKTRACE SOARS TO NEW HIGH

$150 MILLION IN CONTRACT VALUE: DARKTRACE SOARS TO NEW HIGH

Published by Gbaf News

Posted on April 18, 2017

4 min read

Last updated: January 21, 2026

Ceramic adhesives market growth trends and projections - Global Banking & Finance Review — An insightful representation of the ceramic adhesives market, highlighting projected growth and trends across key sectors like construction and healthcare, as discussed in the article.

30,000 In-progress Threats Detected Across 2,400 Deployments

Darktrace, the leader in Enterprise Immune System technology, has closed another quarter of phenomenal growth and demand for its unique technology continues, securing contracts with a total value of over $150 million. The Enterprise Immune System has detected 30,000 in-progress cyber-threats across 2,400 deployments worldwide, ranging from Vancouver to Melbourne. Darktrace now has over 375 partners, and 400 employees across 24 global locations. Unknown threats detected by the Enterprise Immune System include the compromise of a video conferencing device, the vulnerability of back-up servers containing senior executive communications, and an emerging attack against a connected refrigeration system.

The Enterprise Immune System is the world’s first and only machine learning technology to detect and fight against in-progress threats in real time. Created by mathematicians from the University of Cambridge, Darktrace’s tried-and-tested AI algorithms learn the normal ‘pattern of life’ of every device and user on the network to defend organizations of all sizes against emerging threats. Unlike traditional approaches that look at past attacks to pre-define and stop threats at the border, the Enterprise Immune System heralds a new era in cyber security by empowering networks to inoculate themselves against threats from within.

“The Enterprise Immune System has revolutionized our security,” commented Terrell Johnson, Systems and Networks Manager, Sunsweet. “The amount of visibility we achieve from its machine learning approach is unmatched. We are now finding anomalies, in real time, that would have taken us weeks, or even months, to find on our own.”

“Our outstanding growth this quarter highlights the fundamental innovation behind our technology,” said Nicole Eagan, CEO, Darktrace. “The Enterprise Immune System is unique in its ability to not only detect but also remediate in-progress threats, including subtle, stealthy attacks, and ‘unknown unknowns’. Proven across thousands of deployments, it is a true manifestation of AI in action making Darktrace’s technology virtually impossible to replicate.”

30,000 In-progress Threats Detected Across 2,400 Deployments

Darktrace, the leader in Enterprise Immune System technology, has closed another quarter of phenomenal growth and demand for its unique technology continues, securing contracts with a total value of over $150 million. The Enterprise Immune System has detected 30,000 in-progress cyber-threats across 2,400 deployments worldwide, ranging from Vancouver to Melbourne. Darktrace now has over 375 partners, and 400 employees across 24 global locations. Unknown threats detected by the Enterprise Immune System include the compromise of a video conferencing device, the vulnerability of back-up servers containing senior executive communications, and an emerging attack against a connected refrigeration system.

The Enterprise Immune System is the world’s first and only machine learning technology to detect and fight against in-progress threats in real time. Created by mathematicians from the University of Cambridge, Darktrace’s tried-and-tested AI algorithms learn the normal ‘pattern of life’ of every device and user on the network to defend organizations of all sizes against emerging threats. Unlike traditional approaches that look at past attacks to pre-define and stop threats at the border, the Enterprise Immune System heralds a new era in cyber security by empowering networks to inoculate themselves against threats from within.

“The Enterprise Immune System has revolutionized our security,” commented Terrell Johnson, Systems and Networks Manager, Sunsweet. “The amount of visibility we achieve from its machine learning approach is unmatched. We are now finding anomalies, in real time, that would have taken us weeks, or even months, to find on our own.”

“Our outstanding growth this quarter highlights the fundamental innovation behind our technology,” said Nicole Eagan, CEO, Darktrace. “The Enterprise Immune System is unique in its ability to not only detect but also remediate in-progress threats, including subtle, stealthy attacks, and ‘unknown unknowns’. Proven across thousands of deployments, it is a true manifestation of AI in action making Darktrace’s technology virtually impossible to replicate.”